American Well Corp.
- AMWL · NYSE
- Services-Business Services, NEC
- Boston, MA
- 562 employees
- CIK 0001393584
Updated from SEC filings through
Top things to know
Executives
- Dr. Ido Schoenberg Chairman and CEO of Amwell 8-K, 2026-11-03
-
Ido Schoenberg Chairman, co-CEO 4, 2026-05-11 -
Mark Hirschhorn Chief Financial Officer 4, 2026-09-03 -
Phyllis Gotlib President, International 4, 2026-09-03 - Paul Francis McNeice Chief Accounting Officer 4, 2026-09-03
- Dmitry Zamansky Chief Product & Tech. Officer 4, 2026-07-01
What leadership is saying
“Health plans and employers want engagement, outcomes and proof, and Amwell’s single platform is built to deliver all three”
Earnings press release (8-K Ex. 99.1), filed November 3, 2026
American Well Corp is a U.S. public company in services-business services, nec (SIC 7389), headquartered in Boston, MA. It trades as AMWL on NYSE. Revenue was $249M in the fiscal year ending December 31, 2025, -2.0% from the year before. It reported about 562 employees. Dr. Ido Schoenberg is Chairman and CEO of Amwell.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $249M 10-K, 2026-02-12 | $254M 10-K, 2026-02-12 | $259M 10-K, 2026-02-12 | $277M 10-K, 2025-02-12 | $253M 10-K/A, 2024-03-01 |
| Operating income | -$105M 10-K, 2026-02-12 | -$218M 10-K, 2026-02-12 | -$692M 10-K, 2026-02-12 | -$276M 10-K, 2025-02-12 | -$179M 10-K/A, 2024-03-01 |
| SG&A | $131M 10-K, 2026-02-12 | $197M 10-K, 2026-02-12 | $213M 10-K, 2026-02-12 | $228M 10-K, 2025-02-12 | $161M 10-K/A, 2024-03-01 |
| Net income | -$95.7M 10-K, 2026-02-12 | -$208M 10-K, 2026-02-12 | -$675M 10-K, 2026-02-12 | -$270M 10-K, 2025-02-12 | -$176M 10-K/A, 2024-03-01 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Dr. Ido Schoenberg | Chairman and CEO of Amwell | 8-K, 2026-11-03 |
| Ido Schoenberg | Chairman, co-CEO | 4, 2026-05-11 |
| Mark Hirschhorn Chief Financial Officer & Chief Operating Officer | Chief Financial Officer | 4, 2026-09-03 |
| Phyllis Gotlib | President, International | 4, 2026-09-03 |
| Paul Francis McNeice | Chief Accounting Officer | 4, 2026-09-03 |
| Dmitry Zamansky | Chief Product & Tech. Officer | 4, 2026-07-01 |
| Dmitry (Dan) Zamansky | Named in proxy bio: Executive Vice President, Chief Product and Technology Officer | DEF 14A, 2026-04-23 |
 Dan Zamansky | Chief Product and Technology Officer | 10-K, 2026-02-12 |
| Stephen Schlegel | Class III director | 8-K, 2026-07-14 |
What American Well Corp does
Amwell is a leading enterprise platform and software company digitally enabling hybrid care. We empower health providers, payers, and innovators to achieve their digital ambitions, enabling a coordinated experience across in-person, virtual and automated care. We provide our clients with the core technology and services necessary to successfully develop and distribute digital care programs that meet their strategic, operational, financial and clinical objectives under their own brands.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Public float | $125M (as of June 30, 2025) | 10-K, February 12, 2026 |
|---|---|---|
| Reportable segments | 1 (period ending September 30, 2026) | 10-Q, November 3, 2026 |
| Latest proxy statement | Meeting April 23, 2026 (filed April 23, 2026) | DEF 14A, April 23, 2026 |
| Auditor | PricewaterhouseCoopers LLP (Boston, Massachusetts, United States) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| October 1, 2026 | Dmitry Zamansky Chief Product & Tech. Officer | Sale | 8,442 | $110K | Form 4, October 5, 2026 |
| October 1, 2026 | Phyllis Gotlib President, International | Sale | 6,677 | $87K | Form 4, October 5, 2026 |
| October 1, 2026 | Paul Francis McNeice Chief Accounting Officer | Sale | 653 | $8K | Form 4, October 5, 2026 |
| October 1, 2026 | Mark Hirschhorn Chief Financial Officer | Sale | 4,282 | $56K | Form 4, October 5, 2026 |
| September 1, 2026 | Mark Hirschhorn Chief Financial Officer | Sale | 10,751 | $127K | Form 4, September 3, 2026 |
| September 1, 2026 | Phyllis Gotlib President, International | Sale | 3,573 | $42K | Form 4, September 3, 2026 |
| September 1, 2026 | Paul Francis McNeice Chief Accounting Officer | Sale | 112 | $1K | Form 4, September 3, 2026 |
| July 1, 2026 | Paul Francis McNeice Chief Accounting Officer | Sale | 653 | $6K | Form 4, July 1, 2026 |
Recent 8-K events
- 8-K filed 2026-11-03
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-08-04
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-07-21
- Item 4.01 Changes in registrant's certifying accountant
- 8-K filed 2026-07-14
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-06-22
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-05-12
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-05-05
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-04-02
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-02-12
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-01-08
- Item 1.01 Entry into a material definitive agreement
Frequently asked questions about American Well Corp
- What does American Well Corp do?
- In its own words, from Item 1 of its 10-K: "Amwell is a leading enterprise platform and software company digitally enabling hybrid care. We empower health providers, payers, and innovators to achieve their digital ambitions, enabling a coordinated experience across in-person, virtual and automated care. We provide our clients with the core technology and services necessary to successfully develop and distribute digital care programs that meet their strategic, operational, financial and clinical objectives under their own brands."
- What is American Well Corp's revenue?
- $249M for the fiscal year ending December 31, 2025, from its 10-K filed February 12, 2026.
- Is American Well Corp profitable?
- American Well Corp reported net income of -$95.7M for the fiscal year ending December 31, 2025.
- How many employees does American Well Corp have?
- About 562 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of American Well Corp?
- Dr. Ido Schoenberg, Chairman and CEO of Amwell, as named in a 8-K filed November 3, 2026.
- Who is the CFO of American Well Corp?
- Mark Hirschhorn, Chief Financial Officer, as named in a 4 filed September 3, 2026.
- Where is American Well Corp headquartered?
- Boston, MA.
- What is American Well Corp's stock ticker?
- AMWL on NYSE.
- What industry is American Well Corp in?
- Services-Business Services, NEC, SIC code 7389.
- What is American Well Corp's website?
- business.amwell.com.
- When does American Well Corp report earnings next?
- February 2, 2027. Source: estimate_8k_pattern.
- Is American Well Corp a public company?
- Yes. American Well Corp files with the SEC under CIK 0001393584 and trades as AMWL.
- Who audits American Well Corp?
- PricewaterhouseCoopers LLP, Boston, Massachusetts, United States, as named in its latest annual report (10-K).
- What is American Well Corp's public float?
- $125M as of June 30, 2025, as reported on the cover of its 10-K filed February 12, 2026.
- How many business segments does American Well Corp report?
- 1 reportable segment for the period ending September 30, 2026, from its 10-Q filed November 3, 2026.
- When is American Well Corp's annual shareholder meeting?
- April 23, 2026, per its proxy statement (DEF 14A) filed April 23, 2026.
- Have American Well Corp insiders traded stock recently?
- Since July 1, 2025, officers and directors reported 38 open-market sales worth about $1.4M and 1 purchase worth about $5K on Forms 4 and 5. The most recent: Dmitry Zamansky (Chief Product & Tech. Officer) sold 8,442 shares on October 1, 2026.